FDA
approval
· 2020-12-28
FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for a fixed-dose combination product of amlodipine and olmesartan medoxomil from Aurobindo Pharma Limited.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)